Amgen 2011 Annual Report Download - page 79

Download and view the complete annual report

Please find page 79 of the 2011 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 184

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184

Our corporate headquarters are located in Thousand Oaks, California. In addition to the properties listed
above, we have undeveloped land at certain U.S. locations, principally in Thousand Oaks, California; Longmont,
Colorado; Louisville, Kentucky; Allentown, Pennsylvania; West Greenwich, Rhode Island; Seattle and Bothell,
Washington; and in Juncos, Puerto Rico, to accommodate future expansion, as required. Excluded from the table
above are leased properties that have been abandoned and certain buildings that we still own but are no longer
used in our business. There are no material encumbrances on our properties.
We believe our facilities are suitable for their intended use and, in conjunction with our third-party
contracting manufacturing agreements, provide adequate capacity. We also believe that our existing facilities,
third-party contract manufacturing agreements and our anticipated additions are sufficient to meet our expected
needs. (See Item 1A. Risk Factors — We perform a substantial amount of our commercial manufacturing
activities at our Puerto Rico manufacturing facility and a substantial amount of our clinical manufacturing
activities at our Thousand Oaks, California manufacturing facility; if significant natural disasters or production
failures occur at the Puerto Rico facility, we may not be able to supply these products or, at the Thousand Oaks
facility, we may not be able to continue our clinical trials, — We rely on third-party suppliers for certain of our
raw materials, medical devices and components and — Manufacturing difficulties, disruptions or delays could
limit supply of our products and limit our product sales.)
Item 3. LEGAL PROCEEDINGS
Certain of the legal proceedings in which we are involved are discussed in Note 18, Contingencies and
commitments, to our Consolidated Financial Statements in this Annual Report on Form 10-K, and are hereby
incorporated by reference.
Item 4. MINE SAFETY DISCLOSURES
Not applicable.
63